Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD The guidelines for healthy eating encourage a balance of many things, but doesn’t address the specific amount of carbohydrates, protein, and fat. And with so many fad diets circulating, how do we develop informed dietary recommendations for our patients with type 2 diabetes? Dr. Kathleen Stanley, a registered dietitian and certified diabetes educator with the Baptist Health Center discusses factors to take into consideration when making these decisions.

Diabetes Discourse

Fad Diets & Patients with Type 2 Diabetes

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Physical activity is a valuable tool in treating patients with type 2 diabetes. But there are several factors clinicians must consider before prescribing exercise, including patient preference and limitations. Dr. John Anderson sits down with Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss considerations when prescribing exercise to patients with type 2 diabetes.

Cardio Considerations: Individualized Exercise & Patients with Type 2 Diabetes

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Exercise is an essential part of maintaining a healthy lifestyle, especially when managing a chronic condition such as type 2 diabetes. But what should we take into consideration when prescribing it? Dr. John Anderson is joined by Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss exercise prescriptions for patients with type 2 diabetes.

Prescribing Exercise for Patients with Type 2 Diabetes

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Dietary decisions play a critical supporting role in the treatment of patients with type 2 diabetes. What kind of impact do these nutritional interventions have? Dr. Kathleen Stanley, a registered dietitian and certified diabetes educator with the Baptist Health Center joins Dr. John Anderson to discuss the impact of dietary recommendations on patients with type 2 diabetes.

Dietary Decisions for Treating Patients with Type 2 Diabetes

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Adhering to treatment can be challenging for many patients with diabetes. Especially for patients on bolus insulin, how can we encourage them to stick to treatment? Tune in to hear Diabetes Discourse hosts Drs. John Buse, Carol Wysham, and John Anderson discuss a patient case and strategies to overcome it.

Facing Formidable Diabetic Cases with Patient Persistence & Adherence

Host: John Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Diabetic care looks different for every patient. And with so many different variables, challenging cases can become even more challenging to manage. What can endocrinologists do to overcome complicated cases? Dr. John Anderson is joined by his fellow Diabetes Discourse hosts, Dr. John Buse and Dr. Carol Wysham, to share their experiences with difficult cases and explore strategies to solve them.

Difficulty with Diabetes: Strategies to Overcome Challenging Cases

Host: Carol Wysham, MD Host: John Buse, MD, PhD Host: John Anderson, MD The wintertime presents new challenges for patients with chronic diseases, specifically diabetes. But with the spread of COVID-19, how can we help keep our patients safe all winter long? Tune in to hear our Diabetes Discourse hosts Drs. Carol Wysham, John Buse, and John Anderson discuss strategies to effectively manage patients with diabetes during these winter months. Published December X, 2020

Managing Diabetes & COVID-19 in the Wintertime

Host: John Anderson, MD The outbreak of the COVID-19 pandemic has pushed healthcare professionals to adjust the way they treat patients with chronic conditions like diabetes. Tune in to hear Dr. John Anderson share his experience caring for patients with diabetes amid the pandemic.

Caring for Diabetic Patients During the COVID-19 Pandemic

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD Guest: Charles Wykoff, MD, PhD Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients with diabetes are not receiving routine eye exams and are at risk of vision loss. Making matters worse is the fact that many patients with diabetes remain unaware that this disease can affect their vision. That’s why this discussion with a panel of expert faculty will examine what it means to be proactive in promoting vision screening and minimizing the risk for vision loss with appropriate early treatment in these patients. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy

Host: Anne Peters, MD Guest: Thomas W. Gardner, MD, MS Guest: Diana Shechtman, OD, FAAO Unfortunately, there are many factors that can contribute to a patient’s risk for vision-threatening complications and vision loss due to diabetes. Explore those factors with Dr. Anne Peters, Dr. Thomas Gardner, and Dr. Diana Shechtman, who also discuss how endocrinologists and primary care providers can work together with eye care professionals to actively optimize vision outcomes for patients at risk for diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations

Guest: Regina Benjamin, MD, MS As healthcare providers, it’s our duty to emphasize the importance of preventing the eye-health consequences associated with diabetes, particularly as it pertains to health disparities and underserved populations. This activity featuring Dr. Regina Benjamin serves as a call to action by discussing the essential roles that all healthcare professionals play in the overall eye-health of our patients to reduce visual impairment due to diabetic retinopathy. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

A Call to Action from Regina Benjamin, MD, the 18th U.S. Surgeon General

Guest: Michael H. Davidson, MD Tune in as Dr. Michael Davidson, a preventive cardiologist from the University of Chicago Pritzker School of Medicine, outlines what a diabetes cardiovascular outcomes trial (CVOT) is, the differences between CVOTs and glycemic efficacy trials, and how these studies are designed and assessed. US19HCP00067 July 2019

Diabetes Cardiovascular Outcomes Trials: What You Need to Know

Host: Jennifer Caudle, DO Guest: Christie Ballantyne, MD With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. Joining Dr. Jennifer Caudle to discuss the role of the cardiologist in managing patients with type 2 diabetes is Dr. Christie Ballantyne. US18VZ00285 January 2019

Role of the Cardiologist in T2D Management

Host: Jennifer Caudle, DO Guest: Mikhail Kosiborod, MD Guest: Christie Ballantyne, MD Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss both the challenges and opportunities that arise when collaborating patient care are cardiologists Dr. Mikhail Kosiborod and Dr. Christie Ballantyne. US18VZ00286 January 2019

Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

hubhopper

Diabetes Discourse

hubhopper